2024 Q2 Form 10-Q Financial Statement

#000165495424005410 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $656.0K $472.0K $476.0K
YoY Change 108.25% -0.84% 23.0%
% of Gross Profit
Research & Development $487.0K $354.0K $275.0K
YoY Change -12.25% 28.73% 21.68%
% of Gross Profit
Depreciation & Amortization $6.000K $7.000K $6.000K
YoY Change 0.0% 16.67% -25.0%
% of Gross Profit
Operating Expenses $1.149M $833.00 $757.0K
YoY Change 31.16% -99.89% 21.9%
Operating Profit
YoY Change
Interest Expense $387.0K $103.0K $377.0K
YoY Change -335.98% -72.68% 138.61%
% of Operating Profit
Other Income/Expense, Net $387.0K $103.0K $377.0K
YoY Change -335.98% -72.68% 252.34%
Pretax Income -$762.0K -$730.0K -$380.0K
YoY Change -26.73% 92.11% -26.07%
Income Tax
% Of Pretax Income
Net Earnings -$762.0K -$730.0K -$380.0K
YoY Change -26.73% 92.11% -26.07%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 81.29M shares 79.64M shares 64.80M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.464M $1.181M $4.881M
YoY Change -59.6% -75.8% 177.65%
Cash & Equivalents $176.0K $141.0K $440.0K
Short-Term Investments $1.288M $1.040M $4.441M
Other Short-Term Assets $147.0K $205.0K $26.00K
YoY Change -59.84% 688.46% -91.8%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.659M $8.904M $4.907M
YoY Change 142.08% 81.46% -43.53%
LONG-TERM ASSETS
Property, Plant & Equipment $16.85M $16.80M $16.76M
YoY Change 0.04% 0.22% 1.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $104.0K $4.000K $4.000K
YoY Change 2500.0% 0.0% -33.33%
Total Long-Term Assets $16.95M $16.80M $16.76M
YoY Change 0.64% 0.22% 1.9%
TOTAL ASSETS
Total Short-Term Assets $9.659M $8.904M $4.907M
Total Long-Term Assets $16.95M $16.80M $16.76M
Total Assets $26.61M $25.71M $21.67M
YoY Change 27.72% 18.61% -13.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $251.0K $207.0K $188.0K
YoY Change 6.81% 10.11% -18.26%
Accrued Expenses $41.00K $40.00K $25.00K
YoY Change 32.26% 60.0% -32.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $352.0K $247.0K $213.0K
YoY Change 28.47% 15.96% -20.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $154.0K $165.0K $125.0K
YoY Change -21.03% 32.0% -16.67%
Total Long-Term Liabilities $154.0K $165.0K $125.0K
YoY Change -21.03% 32.0% -16.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $352.0K $247.0K $213.0K
Total Long-Term Liabilities $154.0K $165.0K $125.0K
Total Liabilities $506.0K $412.0K $338.0K
YoY Change 7.89% 21.89% -18.94%
SHAREHOLDERS EQUITY
Retained Earnings -$59.13M -$58.37M -$54.27M
YoY Change 6.92% 7.56%
Common Stock $814.0K $796.0K $648.0K
YoY Change 25.42% 22.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.11M $25.29M $21.33M
YoY Change
Total Liabilities & Shareholders Equity $26.61M $25.71M $21.67M
YoY Change 27.72% 18.61% -13.8%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$762.0K -$730.0K -$380.0K
YoY Change -26.73% 92.11% -26.07%
Depreciation, Depletion And Amortization $6.000K $7.000K $6.000K
YoY Change 0.0% 16.67% -25.0%
Cash From Operating Activities -$579.0K -$991.0K -$685.0K
YoY Change -46.39% 44.67% 14.74%
INVESTING ACTIVITIES
Capital Expenditures $67.00K $0.00
YoY Change 644.44% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$437.0K $918.0K $809.0K
YoY Change -138.64% 13.47% -152.13%
Cash From Investing Activities -$504.0K $918.0K $809.0K
YoY Change -144.92% 13.47% -151.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.218M $14.00K 0.000
YoY Change 8600.0% -100.0%
NET CHANGE
Cash From Operating Activities -579.0K -$991.0K -$685.0K
Cash From Investing Activities -504.0K $918.0K $809.0K
Cash From Financing Activities 1.218M $14.00K 0.000
Net Change In Cash 135.0K -$59.00K $124.0K
YoY Change 141.07% -147.58% -205.98%
FREE CASH FLOW
Cash From Operating Activities -$579.0K -$991.0K -$685.0K
Capital Expenditures $67.00K $0.00
Free Cash Flow -$646.0K -$685.0K
YoY Change -40.68% 16.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000917225
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79586358 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79636358 shares
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-39278
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
SOLITARIO RESOURCES CORP.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1285791
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4251 Kipling St. Suite 390
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Wheat Ridge
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80033
CY2024Q1 dei City Area Code
CityAreaCode
303
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
534-1030
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2024Q1 dei Trading Symbol
TradingSymbol
XPL
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81287667 shares
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
200000 usd
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
7518000 usd
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
8436000 usd
CY2024Q1 xpl Investments In Marketable Equity Securities At Fair Value Current
InvestmentsInMarketableEquitySecuritiesAtFairValueCurrent
1040000 usd
CY2023Q4 xpl Investments In Marketable Equity Securities At Fair Value Current
InvestmentsInMarketableEquitySecuritiesAtFairValueCurrent
1032000 usd
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
205000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
273000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
8904000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
9941000 usd
CY2024Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
16646000 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
16646000 usd
CY2024Q1 us-gaap Other Assets
OtherAssets
155000 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
170000 usd
CY2024Q1 us-gaap Assets
Assets
25705000 usd
CY2023Q4 us-gaap Assets
Assets
26757000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
207000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
593000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
40000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
39000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
247000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
632000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
40000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50000 usd
CY2024Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
125000 usd
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
125000 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
165000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
175000 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
796000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
796000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82869000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82796000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58372000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57642000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
25293000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
25950000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25705000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26757000 usd
CY2024Q1 us-gaap Exploration Expense
ExplorationExpense
354000 usd
CY2023Q1 us-gaap Exploration Expense
ExplorationExpense
275000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
472000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
476000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
833 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
757000 usd
CY2024Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
95000 usd
CY2023Q1 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
27000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
21000 usd
CY2024Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
8000 usd
CY2023Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
329000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
103000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
377000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-730000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-380000 usd
CY2024Q1 xpl Earnings Loss Per Share Basic And Diluted
EarningsLossPerShareBasicAndDiluted
-0.01
CY2023Q1 xpl Earnings Loss Per Share Basic And Diluted
EarningsLossPerShareBasicAndDiluted
-0.01
CY2024Q1 xpl Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
79624 shares
CY2023Q1 xpl Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
64801 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-730000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-380000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
9000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
10000 usd
CY2024Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-8000 usd
CY2023Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-329000 usd
CY2024Q1 xpl Unrealized Gain Loss On Short Term Investments
UnrealizedGainLossOnShortTermInvestments
0 usd
CY2023Q1 xpl Unrealized Gain Loss On Short Term Investments
UnrealizedGainLossOnShortTermInvestments
-21000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
59000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
67000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
68000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-396000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-50000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-991000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-685000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
918000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
809000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
918000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
809000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-59000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
124000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
200000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
316000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
141000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
440000 usd
CY2024Q1 xpl Cash And Cash Equivalents Held In Brokerage Accounts And Foreign Banks
CashAndCashEquivalentsHeldInBrokerageAccountsAndForeignBanks
81000 usd
CY2024Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
7518000 usd
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3778500 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5390000 shares
CY2024Q1 us-gaap Mineral Properties Net
MineralPropertiesNet
16646000 usd
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
16646000 usd
CY2024Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
257000 usd
CY2023Q1 us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
232000 usd
CY2024Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
97000 usd
CY2023Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
43000 usd
CY2024Q1 us-gaap Exploration Expense
ExplorationExpense
354000 usd
CY2023Q1 us-gaap Exploration Expense
ExplorationExpense
275000 usd
CY2024Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
125000 usd
CY2024Q1 xpl Available For Sales Securities Current
AvailableForSalesSecuritiesCurrent
1040000 usd
CY2023Q4 xpl Available For Sales Securities Current
AvailableForSalesSecuritiesCurrent
1032000 usd
CY2024Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1440000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1440000 usd
CY2024Q1 xpl Unrealized Gain Loss On Marketable Equity Securities
UnrealizedGainLossOnMarketableEquitySecurities
-400000 usd
CY2023Q4 xpl Unrealized Gain Loss On Marketable Equity Securities
UnrealizedGainLossOnMarketableEquitySecurities
-408000 usd
CY2024Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
1040000 usd
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
1032000 usd
CY2024Q1 xpl Increase In The Fair Value In Its Marketable Equity Securities
IncreaseInTheFairValueInItsMarketableEquitySecurities
8000 usd
CY2023Q1 xpl Increase In The Fair Value In Its Marketable Equity Securities
IncreaseInTheFairValueInItsMarketableEquitySecurities
329000 usd
CY2024Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
125000 usd
CY2024Q1 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
85000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
59000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
67000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
327000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P17M
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
25950000 usd
CY2024Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
59000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-730000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
25293000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
21646000 usd
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
67000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-380000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
21333000 usd

Files In Submission

Name View Source Status
0001654954-24-005410-index-headers.html Edgar Link pending
0001654954-24-005410-index.html Edgar Link pending
0001654954-24-005410.txt Edgar Link pending
0001654954-24-005410-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xpl-20240331.xsd Edgar Link pending
xpl_10q.htm Edgar Link pending
xpl_ex311.htm Edgar Link pending
xpl_ex312.htm Edgar Link pending
xpl_ex321.htm Edgar Link pending
xpl-20240331_def.xml Edgar Link unprocessable
xpl-20240331_lab.xml Edgar Link unprocessable
xpl-20240331_pre.xml Edgar Link unprocessable
xpl_10q_htm.xml Edgar Link completed
xpl-20240331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable